Mannkind (MNKD) Interest Coverage Ratio Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.32% |
| Dec 31, 2025 | 23.10% |
| Sep 30, 2025 | 29.23% |
| Jun 30, 2025 | 35.37% |
| Mar 31, 2025 | 22.17% |
| Dec 31, 2024 | 28.66% |
| Sep 30, 2024 | 39.75% |
| Jun 30, 2024 | 16.45% |
| Mar 31, 2024 | 17.98% |
| Dec 31, 2023 | 17.46% |
| Sep 30, 2023 | 15.81% |
| Jun 30, 2023 | 15.11% |
| Mar 31, 2023 | 32.11% |
| Dec 31, 2022 | 20.15% |
| Sep 30, 2022 | 22.47% |
| Jun 30, 2022 | 25.07% |
| Mar 31, 2022 | -1.32% |
| Dec 31, 2021 | -17.09% |
| Sep 30, 2021 | -15.81% |
| Jun 30, 2021 | 6.72% |
| Mar 31, 2021 | 27.35% |
| Dec 31, 2020 | 45.90% |
| Sep 30, 2020 | -6.61% |
| Jun 30, 2020 | -4.63% |
| Mar 31, 2020 | -12.15% |
| Dec 31, 2019 | -15.87% |
| Sep 30, 2019 | 21.32% |
| Jun 30, 2019 | 7.55% |
| Mar 31, 2019 | -17.34% |
| Dec 31, 2018 | -25.08% |
| Sep 30, 2018 | -15.94% |
| Jun 30, 2018 | 3.70% |
| Mar 31, 2018 | -3.25% |
| Dec 31, 2017 | -41.03% |
| Sep 30, 2017 | 0.35% |
| Jun 30, 2017 | 3.39% |
| Mar 31, 2017 | 11.28% |
| Dec 31, 2016 | 18.19% |
| Sep 30, 2016 | 34.88% |
| Jun 30, 2016 | 19.85% |
| Mar 31, 2016 | 21.34% |
| Dec 31, 2015 | -48.51% |
| Sep 30, 2015 | 22.66% |
| Jun 30, 2015 | 28.32% |